Insulin-based Strategies to Prevent Hypoglycemia During Two Types of Exercise

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-30

Study Completion Date

2024-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Regular exercise is associated with many health benefits for individuals with type 1 diabetes. However, immediate and delayed exercise-induced hypoglycemia is frequent and thus the main limiting factor for physical activity practice in this population. To reduce the risk of exercise-induced hypoglycemia, two types of adjustments may be considered by patients with type 1 diabetes : pre-meal insulin-dose reduction and carbohydrate supplements. Few evidence-based recommendations are available for patients using insulin pump to adjust insulin doses in order to limit exercise-induced hypoglycemia. The objective of this study is to address the magnitude of the needed reduction during two types of frequently practiced exercise (continuous vs. interval exercise) known to have a different impact on blood glucose reduction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Insulin-based Strategies to Prevent Hypoglycemia During Exercise

NCT02631265

Type 1 Diabetes

COMPLETED NA

Carbohydrate-based Strategies to Prevent Exercise-induced Hypoglycemia

NCT03214107

Type 1 Diabetes Mellitus

COMPLETED NA

Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes

NCT04876079

Type 1 Diabetes

COMPLETED NA

Treatment of Hypoglycemia in Type 1 Diabetes

NCT03489967

Type 1 Diabetes

COMPLETED NA

Naloxone, Hypoglycemia and Exercise

NCT03149770

Diabetes Mellitus, Type 1

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each study participant will be admitted at IRCM one to five days after sensor insertion. Participants will be asked to change their pump catheter 24 to 36 hours prior to the intervention visit. On the day of the intervention visit, participants will have a standardized lunch (45-65g CHO for females and 60-80g CHO for males ) at 12:00 and will be asked not to eat afterwards (except for correction of hypoglycemia). Participants will be asked not to exercise (excluding light exercise such as walking or taking the stairs) the day before and the day of the intervention visit. Participants will be asked not to consume caffeine after 12:00 the day of the intervention. The day before the intervention and the day of the intervention, participants will be asked to refrain from alcohol consumption. Participants will be blinded to the strategy used during the exercise intervention. Participants will be admitted at IRCM at 14:00. A catheter will be installed for plasma glucose and insulin measurements. At 14:30, insulin basal rate will be reduced by 40% or 80% depending of randomization. At 15:30, participants will undertake a continuous exercise (60-minute exercise on the ergocycle at 60% of VO2 peak) or an interval exercise (2-minutes alternating intervals at 85% and 50% of VO2peak for 50-minutes, with 5-minutes at 45% VO2peak at the start and the end of exercise). As a safety measure, plasma glucose will be measured every 10 minutes. Participants will be blinded to sensor glucose levels as well as plasma glucose measurements. At 17:00, the participant will be discharged if glucose levels are above 5.5 mmol/L. Participants will be asked to eat a standardized dinner at home (45-65g CHO for females and 60-80g CHO for males). Participants will have the freedom to choose at what time they wish to have dinner but it will have to be similar on all intervention visits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Continuous exercise - Basal insulin reduced by 40%

Group Type ACTIVE_COMPARATOR

Continous exercise

Intervention Type OTHER

60-minute continuous exercise on the ergocycle at 60% of VO2 peak (moderate intensity).

Reduction of basal insulin by 40%

Intervention Type OTHER

Participant's insulin basal rate will be reduced by 40% 1 hour before exercise onset.

Continuous exercise - Basal insulin reduced by 80%

Group Type ACTIVE_COMPARATOR

Continous exercise

Intervention Type OTHER

60-minute continuous exercise on the ergocycle at 60% of VO2 peak (moderate intensity).

Reduction of basal insulin by 80%

Intervention Type OTHER

Participant's insulin basal rate will be reduced by 80% 1 hour before exercise onset.

Interval exercise - Basal insulin reduced by 40%

Group Type ACTIVE_COMPARATOR

Interval exercise

Intervention Type OTHER

Participants will perform a 60-minute interval exercise on the ergocycle at 60% of VO2 peak (moderate intensity).

Reduction of basal insulin by 40%

Intervention Type OTHER

Participant's insulin basal rate will be reduced by 40% 1 hour before exercise onset.

Interval exercise - Basal insulin reduced by 80%

Group Type ACTIVE_COMPARATOR

Interval exercise

Intervention Type OTHER

Participants will perform a 60-minute interval exercise on the ergocycle at 60% of VO2 peak (moderate intensity).

Reduction of basal insulin by 80%

Intervention Type OTHER

Participant's insulin basal rate will be reduced by 80% 1 hour before exercise onset.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continous exercise

60-minute continuous exercise on the ergocycle at 60% of VO2 peak (moderate intensity).

Intervention Type OTHER

Interval exercise

Participants will perform a 60-minute interval exercise on the ergocycle at 60% of VO2 peak (moderate intensity).

Intervention Type OTHER

Reduction of basal insulin by 40%

Participant's insulin basal rate will be reduced by 40% 1 hour before exercise onset.

Intervention Type OTHER

Reduction of basal insulin by 80%

Participant's insulin basal rate will be reduced by 80% 1 hour before exercise onset.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Males and females ≥ 14 years of old.
2. Clinical diagnosis of type 1 diabetes for at least two years.
3. The subject will have been on insulin pump therapy for at least 3 months.
4. Last (less than 2 months) HbA1c ≤ 10%.

Exclusion Criteria

1. Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate below 40 ml/min), neuropathy or severe proliferative retinopathy as judged by the investigator.
2. Recent (\< 3 months) acute macrovascular event e.g. acute coronary syndrome or cardiac surgery.
3. Abnormal blood panel and/or anemia.
4. Ongoing pregnancy.
5. Severe hypoglycemic episode within two weeks of screening.
6. Other serious medical illness likely to interfere with study participation or with the ability to complete the exercise periods by the judgment of the investigator (e.g. orthopedic limitation).
7. Failure to comply with team's recommendations (e.g. not willing to change pump parameters, etc.).

Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No